Market Overview:
The global echinacoside market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for natural and herbal products across the globe. Additionally, rising awareness about the health benefits associated with echinacoside is also propelling the growth of this market. Based on type, less than 98% segment held a dominant share in 2017 and is projected to maintain its dominance throughout the forecast period. This can be attributed to its high demand from various applications such as antioxidative, anti-inflammatory, neuroprotective and hepatoprotective applications.
Product Definition:
A glycoside found in the roots of echinacea, a medicinal herb. Echinacoside has been found to have antiviral and immunostimulant effects.
Less Than 98%:
It is the minimum percentage of impurities that can be tolerated in a drug. In the pharmaceutical industry, it is considered as a standard benchmark for quality control and monitoring purposes. For instance, if an active pharmaceutical ingredient (API) has less than 98% purity, it means that 2% or more of the API contains impurities which must be removed to achieve 98%.
More Than 98%:
More than 98% is a technical term used for the concentration of Echinacoside above 98% in a particular solution. More than 98% means more than the exact amount required to obtain an overall yield of 100%. It is also known as super excess.
Application Insights:
The antioxidant segment held the largest market share in 2017. This is attributed to the rising demand for echinacoside from various applications, such as food additives, cosmetics and nutraceuticals. The product has been used as an antioxidant since centuries owing to its ability to scavenge free radicals and prevent chain reactions resulting in cell damage. It also possesses anti-inflammatory properties which are likely to drive its demand over the forecast period.
Echinacoside has a high potential of becoming a safe compound with low toxicity levels which can be used for treating chronic diseases including heart diseases, cancer and diabetes without any side effects or adverse reactions observed so far. These factors are expected to increase consumer awareness regarding echinacoside benefits leading them towards future growth avenues during the study period (2016 -2030).
Regional Analysis:
North America echinacoside market is expected to grow at a significant rate over the forecast period. The growth of this region can be attributed to the presence of major companies such as Pfizer, Inc.; Merck & Co., Inc.; and EMD Millipore. These companies are engaged in extensive research activities for developing novel drugs with natural ingredients. Thus, increasing R&D expenditure by these entities is anticipated to fuel the industry growth in near future.
Asia Pacific was estimated as the largest echinacoside consuming region in 2017 owing to high product demand from China and Japan on account of rising consumer awareness regarding health benefits associated with echinacea extracts coupled with growing healthcare spending capacity in these countries.
Growth Factors:
- Increasing demand for herbal supplements and nutraceuticals
- Rising awareness about the health benefits of echinacoside
- Growing popularity of traditional Chinese medicine (TCM)
- Proliferation of online retail channels
- Expanding applications for echinacoside in food, cosmetics, and pharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Echinacoside Market Research Report
By Type
Less Than 98%, More Than 98%
By Application
Antioxidative, Anti-Inflammatory, Neuroprotective, Hepatoprotective, Nitric Oxide Radical-Scavenging, Vasodilative
By Companies
BOC Sciences, Carl ROTH, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Cayman Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Echinacoside Market Report Segments:
The global Echinacoside market is segmented on the basis of:
Types
Less Than 98%, More Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antioxidative, Anti-Inflammatory, Neuroprotective, Hepatoprotective, Nitric Oxide Radical-Scavenging, Vasodilative
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- Carl ROTH
- BLDpharm
- Pharmaffiliates
- ChemScence
- AdooQ BioScience
- ApexBio Technology
- EXTRASYNTHESE
- Merck
- Abcam
- Targetmol
- Cayman Chemical
Highlights of The Echinacoside Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Less Than 98%
- More Than 98%
- By Application:
- Antioxidative
- Anti-Inflammatory
- Neuroprotective
- Hepatoprotective
- Nitric Oxide Radical-Scavenging
- Vasodilative
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Echinacoside Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Echinacoside is a natural compound found in the root of the Chinese yam, Dioscorea opposita. It has been shown to have anti-inflammatory and antioxidant properties.
Some of the key players operating in the echinacoside market are BOC Sciences, Carl ROTH, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Abcam, Targetmol, Cayman Chemical.
The echinacoside market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Echinacoside Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Echinacoside Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Echinacoside Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Echinacoside Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Echinacoside Market Size & Forecast, 2020-2028
4.5.1 Echinacoside Market Size and Y-o-Y Growth
4.5.2 Echinacoside Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Less Than 98%
5.2.2 More Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antioxidative
6.2.2 Anti-Inflammatory
6.2.3 Neuroprotective
6.2.4 Hepatoprotective
6.2.5 Nitric Oxide Radical-Scavenging
6.2.6 Vasodilative
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Echinacoside Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Echinacoside Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Less Than 98%
9.6.2 More Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antioxidative
9.10.2 Anti-Inflammatory
9.10.3 Neuroprotective
9.10.4 Hepatoprotective
9.10.5 Nitric Oxide Radical-Scavenging
9.10.6 Vasodilative
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Less Than 98%
10.6.2 More Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antioxidative
10.10.2 Anti-Inflammatory
10.10.3 Neuroprotective
10.10.4 Hepatoprotective
10.10.5 Nitric Oxide Radical-Scavenging
10.10.6 Vasodilative
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Less Than 98%
11.6.2 More Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antioxidative
11.10.2 Anti-Inflammatory
11.10.3 Neuroprotective
11.10.4 Hepatoprotective
11.10.5 Nitric Oxide Radical-Scavenging
11.10.6 Vasodilative
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Less Than 98%
12.6.2 More Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antioxidative
12.10.2 Anti-Inflammatory
12.10.3 Neuroprotective
12.10.4 Hepatoprotective
12.10.5 Nitric Oxide Radical-Scavenging
12.10.6 Vasodilative
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Less Than 98%
13.6.2 More Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antioxidative
13.10.2 Anti-Inflammatory
13.10.3 Neuroprotective
13.10.4 Hepatoprotective
13.10.5 Nitric Oxide Radical-Scavenging
13.10.6 Vasodilative
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Echinacoside Market: Competitive Dashboard
14.2 Global Echinacoside Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 Carl ROTH
14.3.3 BLDpharm
14.3.4 Pharmaffiliates
14.3.5 ChemScence
14.3.6 AdooQ BioScience
14.3.7 ApexBio Technology
14.3.8 EXTRASYNTHESE
14.3.9 Merck
14.3.10 Abcam
14.3.11 Targetmol
14.3.12 Cayman Chemical
